Rofecoxib and clinically significant gastrointestinal events

Am J Med Sci. 2011 Nov;342(5):438-9. doi: 10.1097/MAJ.0b013e31822f3ff4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cyclooxygenase 2 Inhibitors / adverse effects*
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Tract / drug effects*
  • Humans
  • Lactones / adverse effects*
  • Lactones / pharmacology*
  • Legislation, Drug*
  • Sulfones / adverse effects*
  • Sulfones / pharmacology*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib